Astegolimab

(Synonyms: MSTT 1041A; RG 6149)
3 Cited Publications
Customer Review

Based on 3 publication(s) in Google Scholar

Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody. Astegolimab blocks IL-33 signaling by targeting the IL-33 receptor ST2. Astegolimab reduces p53 expression, mitigates IL33-upregulated SASP factors such as IL1α, IL6 and MCP1. Astegolimab mitigates IL33-increased p-p65/p65 ratio. Astegolimab blocks CM-induced neutrophil extracellular trap (NET) formation. Astegolimab is used in chronic obstructive pulmonary disease (COPD) and myocardial research.

For research use only. We do not sell to patients.

  • Purity: 99.00%
  • CAS No.: 2173054-79-8
  • Molecular Weight:144.98 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Customer Validation & Images
ELISAWB
  • ELISA
  • WB
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00